Antihypertensive effects of selective prostaglandin E2 receptor subtype 1 targeting.
Guan Y, Zhang Y, Wu J, Qi Z, Yang G, Dou D, Gao Y, Chen L, Zhang X, Davis LS, Wei M, Fan X, Carmosino M, Hao C, Imig JD, Breyer RM, Breyer MD.
Guan Y, et al. Among authors: carmosino m.
J Clin Invest. 2007 Sep;117(9):2496-505. doi: 10.1172/JCI29838.
J Clin Invest. 2007.
PMID: 17710229
Free PMC article.